# Lakefront Biotherapeutics NV: Form 6-K, filed Oct 9, 2026

- Company: [Lakefront Biotherapeutics NV](/companies/lkft.md) (CIK 1421876)
- Form: 6-K
- Filed: 2026-10-09
- Accepted by EDGAR: Oct 9, 2026, 17:26 ET
- Period: 2026-10-08
- Accession: 0001171843-26-006564
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1421876/000117184326006564/f6k_100926.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1421876/000117184326006564/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1421876/000117184326006564/f6k_100926.htm

Filed Oct 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-006564. Last ingested by Listed: Nov 12, 2026, 17:23 ET. No prices; not investment advice.
